Ask Indegene Icon

Ask Indegene (Beta)

Online
đź§  Building on our previous conversation...

Hello, how can I help you today?

You may type your question or choose from the options below:

Explore Solutions
Browse Insights
View Case Studies
Read Latest News
Explore Careers
Connect with an Expert
Please enter your full name
Please enter a valid work email
Please enter your message

Thank you!

We'll be in touch. In the meantime, feel free to keep exploring!

#FutureReadyHealthcare
Indegene
Search Icon
Indegene Launches NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI
Home
News NEXT Medical Writing Automation Launch

Indegene Launches NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI

11 Jul 2025

Princeton, US, July 11, 2025: Indegene, a digital-first, life sciences commercialization company, today announced the launch of NEXT Medical Writing Automation, an advanced platform that combines deep medical writing expertise with generative AI (GenAI) to accelerate the creation of high-quality, compliant documents across clinical development, regulatory submissions, and beyond.

Medical writing teams are under constant pressure to deliver precise, regulatory-ready documents within tight timelines, often while navigating fragmented data and evolving compliance needs. NEXT Medical Writing Automation addresses these challenges head-on. It combines Indegene’s decades of domain knowledge with the power of its AI engine, Cortex. As a life sciences-specialist knowledge engineering and multi-agent orchestration platform, Cortex by Indegene enables life sciences leaders to adopt and scale this transformative technology with enterprise-grade governance.

Purpose-built by experienced medical writers, NEXT Medical Writing Automation operates within familiar environments like Microsoft Word, auto-generating compliant drafts that adapt to diverse sponsor formats and workflows. It integrates seamlessly with Regulatory Information Management (RIM) systems, maintaining traceability and consistency across documents.

With automated scheduling, intelligent task assignments, and robust data flow integration, NEXT Medical Writing Automation helps life sciences organizations scale operations efficiently while maintaining a strong compliance backbone. As document requirements grow and scrutiny intensifies, such solutions become essential to sustaining operational excellence. “We see this platform as more than automation—it’s about elevating the entire practice of medical writing,” said Sameer Lal, SVP, Enterprise Medical Solutions, Indegene. “Writers can now focus on strategic tasks and critical thinking, while the platform manages the heavy lift of data and formatting.”

The launch of NEXT Medical Writing Automation is consistent with Indegene’s ongoing commitment to advancing medical writing capabilities. It also builds on Indegene’s strategic growth, following the acquisition of Trilogy Writing & Consulting GmbH (Trilogy) last year, a global provider of specialty medical writing services across clinical, regulatory, safety, and medical content. Together, these strengthen Indegene’s ability to support market authorization applications and deliver comprehensive medical writing solutions worldwide.

About Indegene

Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations to be future-ready. To learn more, please visit www.indegene.com

Latest

Powered by Onetrust